RankingsPricing
  1. US-listed companies
  2. MoonLake Immunotherapeutics
  3. Raw

MoonLake ImmunotherapeuticsMLTX

Market cap
$895.64M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents1666,79040451180
Short-term marketable debt securities--3360268
Other receivables--217,12913
Prepaid Expense, Current283,057126,9164223
Total current assets2793,70677514474
Operating lease right-of-use assets--282,58043
Property and equipment, net--49,389320,865722,226
Prepaid Expense, Noncurrent---8-
Total non-current assets115115331,969124
Total assets11711677527478
Trade and other payables--254,97229
Operating Lease, Liability, Current--011
Accrued Liabilities and Other Liabilities--7712
Total current liabilities125,183481022
Operating Lease, Liability, Noncurrent--128,95121
Pension liability--282,206583,426620,684
Total non-current liabilities44411,15732
Total liabilities4881325
Common Class A118-3,8986,0476,308
Common Class C--1,37325184
Common Shares-43---
Additional paid-in capital5-129610677
Accumulated deficit-90,838-7,059,268-80,650,212-116,657,472-235,592,989
Accumulated other comprehensive income--350,94625
Common Class A118----
Total shareholders’ equity5-7,058,93769513453
Noncontrolling interests--20187
Common Class A--3,8986,0476,308
Common Class C--1,37325184
Total equity--69513453
Total liabilities and equity11711677527478